With wide clinical demands, therapies for traumatic brain injury (TBI) are far from satisfactory.
Combining the merits of stem cells but avoiding the risk of immunologic rejection, bone …

Cerebral vessels are composed of highly complex structures that facilitate blood perfusion
necessary for meeting the high energy demands of the brain. Their geometrical complexities …

The coronary artery bypass grafting is a main treatment for restoring the blood supply to the
ischemic site by bypassing the narrow part, thereby improving the heart function of the …

The extracellular matrix (ECM) is a dynamic and complex network of proteins and molecules
that surrounds cells and tissues in the nervous system and orchestrates a myriad of …

Background Parkinson's disease (PD) is one of the most common long-term
neurodegenerative diseases. Current treatments for PD are mostly based on surgery and …

Regenerating brain defects after traumatic brain injury (TBI) still remains a significant
difficulty, which has motivated interest in 3D printing to design superior replacements for …

Organ‐on‐a‐chip technology has shown great potential in disease modeling and drug
evaluation. However, traditional organ‐on‐a‐chip devices are mostly pump‐dependent with …

The use of human neural stem cells (hNSCs) for clinical cell therapies is limited by the lack
of effective culture substrates to produce hNSCs. Animal-sourced substrates could result in …

Damaged neurons and harsh microenvironments contribute to the injury cascades following
traumatic brain injury (TBI). Mesenchymal stem cell (MSC) therapy is considered a viable …

Central nervous system (CNS) diseases are a leading cause of death and disability. Due to
CNS neurons have no self-renewal and regenerative ability as they mature, their loss after …